CIK 0001382101 · Non-accelerated filer<br>Smaller reporting company
SUTRO BIOPHARMA, INC.
Sign in to watch- Ticker
- STRO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 452441988
- Phone
- 650-392-8412
- Business address
- 111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Former names
- SUTRO BIOPHARMA INC, Fundamental Applied Biology Inc
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Agreement ended · Results of operations
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 2 of 32 · 625 filings